Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

Influence of aflibercept on platelet activation profile.

Sobolewska B, Golenko J, Poeschel S, Grimmel C, Gatsiou A, Sopova K, Biedermann T, Schenke-Layland K, Stellos K, Ziemssen F.

Exp Eye Res. 2018 Oct;175:166-172. doi: 10.1016/j.exer.2018.06.009. Epub 2018 Jun 15.

PMID:
29908884
2.

YB-1 Expression and Phosphorylation Regulate Tumorigenicity and Invasiveness in Melanoma by Influencing EMT.

Kosnopfel C, Sinnberg T, Sauer B, Busch C, Niessner H, Schmitt A, Forchhammer S, Grimmel C, Mertens PR, Hailfinger S, Dunn SE, Garbe C, Schittek B.

Mol Cancer Res. 2018 Jul;16(7):1149-1160. doi: 10.1158/1541-7786.MCR-17-0528. Epub 2018 May 9.

3.

The clinical relevance of birch pollen profilin cross-reactivity in sensitized patients.

Wölbing F, Kunz J, Kempf WE, Grimmel C, Fischer J, Biedermann T.

Allergy. 2017 Apr;72(4):562-569. doi: 10.1111/all.13040. Epub 2016 Sep 28.

PMID:
27588729
4.

Different Effects of Ranibizumab and Bevacizumab on Platelet Activation Profile.

Sobolewska B, Grimmel C, Gatsiou A, Sopova K, Klein J, Biedermann T, Stellos K, Ziemssen F.

Ophthalmologica. 2015;234(4):195-210. doi: 10.1159/000437057. Epub 2015 Aug 21.

PMID:
26305017
5.

Para-phenylenediamine-specific lymphocyte activation test: a sensitive in vitro assay to detect para-phenylenediamine sensitization in patients with severe allergic reactions.

Kneilling M, Caroli U, Grimmel C, Fischer J, Eichner M, Wieder T, Maier FC, Röcken M, Biedermann T.

Exp Dermatol. 2010 May;19(5):435-41. doi: 10.1111/j.1600-0625.2009.01043.x. Epub 2010 Jan 25.

PMID:
20113350
6.

Ezrin-dependent promotion of glioma cell clonogenicity, motility, and invasion mediated by BCL-2 and transforming growth factor-beta2.

Wick W, Grimmel C, Wild-Bode C, Platten M, Arpin M, Weller M.

J Neurosci. 2001 May 15;21(10):3360-8.

7.

Secreted Frizzled-related proteins inhibit motility and promote growth of human malignant glioma cells.

Roth W, Wild-Bode C, Platten M, Grimmel C, Melkonyan HS, Dichgans J, Weller M.

Oncogene. 2000 Aug 31;19(37):4210-20.

8.

Bag-1 and Bcl-2 gene transfer in malignant glioma: modulation of cell cycle regulation and apoptosis.

Roth W, Grimmel C, Rieger L, Strik H, Takayama S, Krajewski S, Meyermann R, Dichgans J, Reed JC, Weller M.

Brain Pathol. 2000 Apr;10(2):223-34.

PMID:
10764042
9.
10.

TGF-beta-independent induction of immunogenicity by decorin gene transfer in human malignant glioma cells.

Münz C, Naumann U, Grimmel C, Rammensee HG, Weller M.

Eur J Immunol. 1999 Mar;29(3):1032-40.

11.

Predicting chemoresistance in human malignant glioma cells: the role of molecular genetic analyses.

Weller M, Rieger J, Grimmel C, Van Meir EG, De Tribolet N, Krajewski S, Reed JC, von Deimling A, Dichgans J.

Int J Cancer. 1998 Dec 18;79(6):640-4.

13.

Hypericin-induced apoptosis of human malignant glioma cells is light-dependent, independent of bcl-2 expression, and does not require wild-type p53.

Weller M, Trepel M, Grimmel C, Schabet M, Bremen D, Krajewski S, Reed JC.

Neurol Res. 1997 Oct;19(5):459-70.

PMID:
9329022

Supplemental Content

Loading ...
Support Center